Coaching Clients Through Stopping a GLP-1 Medication

A client telling you they are stopping their GLP-1 medication is not the end of a coaching relationship. It is the start of the most important part of it, provided their physician or prescriber is already steering the timeline. The discontinuation window is where most GLP-1 related weight regain actually happens, and a coach’s job through it is narrow but critical: confirm the client’s clinician is managing the taper, then build a step down program around returning appetite, changing energy, and the habit work that keeps hard-earned strength and body composition changes in place. Book the first step down session once the client confirms their prescriber has cleared the plan, not before.

Confirm the clinical picture before programming anything

Open every step down conversation the same way: ask whether the client is working with their prescriber on the timeline and whether any symptoms or monitoring have been discussed. This is not a formality. Appetite, energy, and sometimes mood can shift meaningfully as the medication clears the system, and a coach who does not know that a taper is medically supervised is coaching blind. Nothing in this program substitutes for that relationship, and nothing a coach observes in a session should be treated as a reason to advise for or against continuing the medication.

Everything that follows lives strictly on the training side of that line. A coach observes, programs, and adjusts training variables; a coach does not diagnose why hunger has returned, does not comment on whether a taper is proceeding normally, and does not suggest a client extend, shorten, or restart their medication based on how a session went. When a client raises a symptom, a mood change, or a question about the medication itself mid-session, the right response is the same every time: note it, and route the question back to the prescriber rather than offering a guess.

Why the step down window carries the highest regain risk

The mechanism driving this window’s risk is straightforward. The medication had been suppressing appetite, and as it clears, hunger cues that were quiet for months can return, sometimes gradually and sometimes fast. Research on stopping the medications consistently points to the same finding: weight regain is common when no maintenance plan is in place for this specific window, which makes the weeks around discontinuation the highest leverage moment in the entire coaching relationship, not a wind down toward a quieter program.

Programming principles for the step down

Hold the training side steady rather than easing off just because the medication side is changing. Keep resistance training frequency where it has been, since the strength and muscle a client built during the medicated period is the asset most worth protecting through this transition. Reinforce protein-forward eating habits in general terms, appropriate for a coach’s scope, as appetite returns and old cravings resurface alongside it. Increase check-in frequency temporarily, weekly rather than monthly, since this is a period of genuine physiological change and a coach who is not watching closely will miss the early signs of drift. And keep expectations realistic and spoken out loud: some renegotiation of habits during this window is normal, not a sign the client or the program has failed.

Questions to have the client bring to their clinician first

Before the step down program begins in earnest, encourage the client to ask their prescriber a short list of questions, and build the training calendar around whatever answers come back. Worth asking: what timeline should they expect for appetite and energy to shift, what symptoms would warrant a call back to the clinic, whether any labs or follow-up visits are scheduled during the taper, and when the clinician considers it appropriate to return to normal training intensity if anything was scaled back during the medicated period. A coach who has seen these answers can program with real information instead of guessing at where a client stands.

Holding the scope line consistently is what makes a coach trustworthy to both the client and the medical team managing the bigger picture, and it also happens to be good business. Coaches who handle the step down period competently tend to keep these clients longer than coaches who quietly wait for the relationship to fade once the weight loss phase ends. A client moving into discontinuation still needs structure, arguably more than before, and a coach who names that need explicitly and builds a program around it becomes the obvious person to keep training with rather than a service that was tied to the medicated phase alone. It also strengthens referral relationships: a prescriber who sees a patient maintain their results after tapering off is far more likely to keep sending new patients your way. Because this window often calls for a temporarily lighter or more flexible schedule while a client’s energy resettles, booking a room only for the sessions that actually happen keeps your costs matched to a calendar that may look different for a few months than it did during the medicated phase.

Where this fits the wider GLP-1 business line

This window sits downstream of two decisions covered elsewhere: whether to invest in a GLP-1 coaching certification at all, and how to market to this client base without leading with the medication. The muscle-preserving programming that matters throughout a client’s time on the medication, detailed in how trainers help GLP-1 clients avoid muscle loss, does not stop mattering once the taper begins. If anything, the step down period is where that earlier programming work finally gets tested, since a client walking into discontinuation with real strength and durable habits regains far less than one who lost weight without ever building either.

Stay in your lane, confirm the clinical plan is real, and treat the step down as the coaching opportunity it actually is rather than a quiet exit from the relationship.